Cellular Uptake and Cytosolic Delivery of a Cyclic Cystine Knot Scaffold.


Journal

ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906

Informations de publication

Date de publication:
19 06 2020
Historique:
pubmed: 22 4 2020
medline: 27 4 2021
entrez: 22 4 2020
Statut: ppublish

Résumé

Cyclotides are macrocyclic peptides with exceptionally stable structures and have been reported to penetrate cells, making them promising scaffolds for the delivery of inhibitory peptides to target intracellular proteins. However, their cellular uptake and cytosolic localization have been poorly understood until now, which has limited their therapeutic potential. In this study, the recently developed chloroalkane penetration assay was combined with established assays to characterize the cellular uptake and cytosolic delivery of the prototypic cyclotide, kalata B1. We show that kalata B1 enters the cytosol at low efficiency. A structure-activity study of residues in loop 6 showed that some modifications, such as increasing cationic residue content, did not affect delivery efficiency, whereas others, including introducing a single hydrophobic amino acid, did significantly improve cytosolic delivery. Our results provide a foundation for the further development of a structurally unique class of scaffolds for the delivery of therapeutic cargoes into cells.

Identifiants

pubmed: 32315152
doi: 10.1021/acschembio.0c00297
pmc: PMC7831380
mid: NIHMS1662879
doi:

Substances chimiques

Cyclotides 0
Fluorescent Dyes 0
kalata B1 0
Cystine 48TCX9A1VT

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1650-1661

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM127585
Pays : United States

Références

Biochemistry. 2016 Jan 19;55(2):396-405
pubmed: 26685975
Angew Chem Int Ed Engl. 2019 Jun 3;58(23):7652-7656
pubmed: 30916847
Chembiochem. 2019 Feb 15;20(4):488-498
pubmed: 30178574
Angew Chem Int Ed Engl. 2012 Jun 4;51(23):5620-4
pubmed: 22532483
J Mol Biol. 1999 Jan 8;285(1):333-45
pubmed: 9878410
Nat Chem. 2018 Jul;10(7):715-723
pubmed: 29713035
J Am Chem Soc. 2014 Jul 16;136(28):9830-3
pubmed: 24972263
Angew Chem Int Ed Engl. 2018 Sep 10;57(37):11868-11881
pubmed: 29740917
J Am Chem Soc. 2017 Jun 14;139(23):7792-7802
pubmed: 28414223
J Biomol NMR. 1995 Sep;6(2):135-40
pubmed: 8589602
Nat Commun. 2014 Nov 17;5:5475
pubmed: 25400104
Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):580-97
pubmed: 18045730
ACS Chem Biol. 2015 Oct 16;10(10):2316-24
pubmed: 26162280
Angew Chem Int Ed Engl. 2017 Aug 21;56(35):10294-10323
pubmed: 28186380
Biochemistry. 2004 May 25;43(20):5965-75
pubmed: 15147180
J Am Chem Soc. 2018 Sep 12;140(36):11360-11369
pubmed: 30118219
Nat Chem. 2019 Jul;11(7):644-652
pubmed: 31182821
J Am Chem Soc. 2013 Aug 7;135(31):11623-11633
pubmed: 23848581
Drug Deliv. 2018 Nov;25(1):928-937
pubmed: 29656676
J Control Release. 2011 Oct 30;155(2):134-43
pubmed: 21906641
Curr Opin Chem Biol. 2016 Oct;34:143-150
pubmed: 27642714
J Org Chem. 2003 Feb 7;68(3):1146-9
pubmed: 12558448
Nat Chem Biol. 2014 Sep;10(9):716-22
pubmed: 25038791
Nat Commun. 2011 Aug 30;2:453
pubmed: 21878907
Chem Biol Drug Des. 2013 Jan;81(1):136-47
pubmed: 23253135
ACS Chem Biol. 2008 Jun 20;3(6):373-82
pubmed: 18533659
Biopolymers. 2013 Sep;100(5):480-91
pubmed: 23893608
J Biol Chem. 2010 Apr 2;285(14):10797-805
pubmed: 20103593
Nat Rev Drug Discov. 2018 Jul 30;17(8):531-533
pubmed: 30057410
Chem Rev. 2019 Sep 11;119(17):10241-10287
pubmed: 31083977
Nat Chem Biol. 2018 May;14(5):417-427
pubmed: 29662187
Acc Chem Res. 2012 Jul 17;45(7):1132-9
pubmed: 22208383
Bioconjug Chem. 2019 Apr 17;30(4):1006-1027
pubmed: 30882208
J Org Chem. 2014 Jun 20;79(12):5538-44
pubmed: 24918986
J Biol Chem. 2012 Sep 28;287(40):33629-43
pubmed: 22854971
Acc Chem Res. 2012 Jul 17;45(7):1048-56
pubmed: 22455499
J Biol Chem. 2012 Dec 21;287(52):43884-98
pubmed: 23129773
Front Pharmacol. 2015 Feb 09;6:17
pubmed: 25709580
Angew Chem Int Ed Engl. 2015 Feb 2;54(6):1950-3
pubmed: 25521313
J Med Chem. 2020 Jan 9;63(1):334-348
pubmed: 31801019
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8
pubmed: 11087855
Chem Biol. 2015 Aug 20;22(8):1087-97
pubmed: 26278183
ACS Comb Sci. 2018 Apr 9;20(4):237-242
pubmed: 29481042
Drug Discov Today. 2012 Aug;17(15-16):850-60
pubmed: 22465171
J Biol Chem. 2011 Oct 21;286(42):36932-43
pubmed: 21873420
J Med Chem. 2008 Dec 25;51(24):7697-704
pubmed: 19053834
ACS Chem Biol. 2013 Feb 15;8(2):423-31
pubmed: 23130658
J Am Chem Soc. 2019 Dec 26;141(51):20460-20469
pubmed: 31765148
Eur J Med Chem. 2014 Dec 17;88:10-8
pubmed: 24985034
Angew Chem Int Ed Engl. 2011 Oct 4;50(41):9633-7
pubmed: 21919161
Biochemistry. 2016 May 10;55(18):2601-12
pubmed: 27089101

Auteurs

Huawu Yin (H)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.

Yen-Hua Huang (YH)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.

Kirsten Deprey (K)

Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States.

Nicholas D Condon (ND)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.

Joshua A Kritzer (JA)

Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States.

David J Craik (DJ)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.

Conan K Wang (CK)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH